Scientists say we’ve been treating Alzheimer’s all wrong

Alzheimer’s disease (AD) remains one of the most pressing global health challenges, especially as aging populations continue to grow. The condition steadily erodes memory and thinking abilities, deeply affecting daily life. New treatments, including monoclonal antibodies such as lecanemab and…

Click here to view the original article.